Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon-Reference-Cited by-同舟云学术

Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon

Published:2015-01 Issue:1 Volume:115 Page:47-51
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Kaess Bernhard M.,Ammar Sonia,Reents Tilko,Dillier Roger,Lennerz Carsten,Semmler Verena,Grebmer Christian,Bourier Felix,Buiatti Alessandra,Kolb Christof,Deisenhofer Isabel,Hessling Gabriele

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

2. Advantages and limitations of the new anticoagulants;Schulman;J Intern Med,2014

3. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association;Camm;Eur Heart J,2012

4. Early management of atrial fibrillation to prevent cardiovascular complications;Nattel;Eur Heart J,2014

5. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin;Kim;Circ Arrhythm Electrophysiol,2013

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation;European Heart Journal Open;2023-06-20

2. The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time;Vascular Pharmacology;2022-06

3. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation;EP Europace;2021-04-25

4. Direct Oral Anticoagulants and Atrial Fibrillation Ablation;Direct Oral Anticoagulants;2021

5. A prospective multicenter study of direct comparison of feasibility and safety of pulmonary vein isolation using the minimally interrupted apixaban between second‐generation cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: J‐HIT apixaban;Journal of Arrhythmia;2020-06-27